Product Categories
| Country: | China |
|---|---|
| Tel: | 21-61263452 |
| Mobile: | 13641803416 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Company Name: | Shanghai GL Peptide Ltd |
| Tel: | 86-21-61263385 |
| Fax: | 86-21-61263399 |
| Email: | ymbetter@glbiochem |
| WebSite: | http://www.glbiochem.com |
| Nationality: | CHINA |
| Product Name | MF | CAS | Details |
|---|
| SIVmac239-71;TNILDVKQGPKEPFQ | C77H124N20O24 | Details |
| SIVmac239-95;IPFAAAQQRGPRKPI | C75H124N24O18 | Details |
| Suc-Arg-Pro-Tyr-pNA;Suc-RPY-pNA | C30H36N8O8 | Details |
| Threonine Phosphopeptide,PKC Substrate 4, phosphorylated;KR-pT-IRR | C34H69N16O11P | Details |
| Theromacin (49-63)??;QRLPNNKQCRCINAR(C57-C59disulfidebridge) | Details |
| SIVmac239-65;IPVGNIYRRWIQLGL | C85H136N24O19 | Details |
| Substance P, FAM-labeled;FAM-RPKPQQFFGLM-NH2 | C84H108N18O19S | Details |
| SIVmac239-81;TLLIQNANPDCKLVL | C73H127N19O22S | Details |
| TGF? activating peptide;KRFK-NH2 | C27H48N10O4 | Details |
| SIVmac239-50;QAAMQIIRDIINEEA | C72H123N21O25S | Details |
| SIVmac239-86;NPTLEEMLTACQGVG | C64H107N17O24S2 | Details |
| Syntide-2 [PLARTLSVAGLPGKK], Biotinylated;Biotin-PLARTLSVAGLPGKK | C78H136N22O20S | Details |
| SIVmac239-69;KCVRMYNPTNILDVK | C78H132N22O22S2 | Details |
| SIVmac239-54;DWDLQHPQPAPQQGQ | C75H107N23O25 | Details |
| SIVmac239-98;KPIKCWNCGKEGHSA | C71H112N22O20S2 | Details |
| SIVmac239-58;REPSGSDIAGTTSSV | C58H98N18O26 | Details |
| SIVmac239-67;RWIQLGLQKCVRMYN | C85H138N26O20S2 | Details |
| Transportan;GWTLNSAGYLLGKINLKALAALAKKIL | C134H227N35O32 | 203716-10-3 | Details |
| T20-Lys(TAMRA);Ac-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF-K(TAMRA)-NH2 | Details |
| Somatostatin 14, acetate;AGCKNFFWKTFTSC(Disulfidebridge:3-14),acetatesalt | C78H108N18O21S2 | 54472-66-1 | Details |
| SIVmac239-93;KEALAPVPIPFAAAQ | C72H115N17O19 | Details |
| Synapsin I-derived peptide, TAMRA-labeled??;5-TAMRA-LRRRLSDANF-NH2 | Details |
| SIVmac239-90;PGQKARLMAEALKEA | C69H121N21O21S | Details |
| SIVmac239-60;AGTTSSVDEQIQWMY | C74H110N18O27S | Details |
| SIVmac239-87;EEMLTACQGVGGPGQ | C59H97N17O23S2 | Details |
| TAT (47-57) GGG-Cys(Npys);YGRKKRRQRRRGGG-C(Npys)-NH2 | C78H135N39O19S2 | Details |
| Syntide-2 [PLARTLSVAGLPGKK], 5-FAM labeled;5-FAM-PLARTLSVAGLPGKK | C89H132N20O24 | Details |
| TNF-FRET (2)??;Mca-PLAQAVRSSSDap(Dnp)R-NH2 | Details |
| TNF-α (73-76);Mca-LAQA | C29H39N5O10 | Details |
| SIVmac239-46;CTPYDINQMLNCVGD | C69H108N18O25S3 | Details |
| SIVmac239-57;QGQLREPSGSDIAGT | C61H102N20O25 | Details |
| SIVmac239-63;WMYRQQNPIPVGNIY | C87H127N23O22S | Details |
| SIVmac239-79;AVKNWMTQTLLIQNA | C77H127N21O22S | Details |
| T20-Lys(HiLyte Fluor?488);Ac-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF-K(HiLyteFluor?488)-NH2 | Details |
| SIVmac239-83;PDCKLVLKGLGVNPT | C69H120N18O20S | Details |
| SIVmac239-7;GKKKYMLKHVVWAAN | C83H133N23O18S | Details |
| Stearyl-MEK-1 Derived Peptide Inhibitor 1, amide;Ste-MPKKKPTPIQLNP-NH2 | C86H153N19O17S | Details |
| SIVmac239-45;LSEGCTPYDINQMLN | C71H112N18O26S2 | Details |
| SIVmac239-6;LRPNGKKGKKKYMLKHVV | C97H170N30O21S | Details |
| SIVmac239-84;LVLKGLGVNPTLEEM | C72H125N17O22S | Details |
| SIVmac239-53;EEAADWDLQHPQPAP | C76H108N20O26 | Details |
| SIVmac239-51;DIINEEAADWD | C55H79N13O23 | Details |
| SIVmac239-82;QNANPDCKLVLKGLG | C67H116N20O21S | Details |
| SIVmac239-97;RGPRKPIKCWNCGKE | C76H126N26O19S2 | Details |
| SIVmac239-89;GVGGPGQKARLMAEA | C60H104N20O19S | Details |
| SIVmac239-61;SSVDEQIQWMYRQQN | C82H123N23O28S | Details |
| Src Optimal Peptide Substrate;AEEEIYGEFEAKKKK | C81H127N19O27 | Details |
| SIVmac239-72;DVKQGPKEPFQSYVD | C78H117N19O26 | Details |
| SIVmac239-52;DIINEEAADWDLQHP | C77H112N20O28 | Details |
| TAT (47-57), FAM-labeled;FAM-YGRKKRRQRRR | C85H128N32O20 | Details |
| SIVmac239-49;VGDHQAAMQIIRDII | C75H128N22O22S | Details |
| Transforming Growth Factor ?1 Peptide, TGF-?1 (60-66), amide;KVLALYNK-NH2 | C45H78N12O10 | Details |
| Syntide-2 [PLARTLSVAGLPGKK], 5-TMR labeled;5-TMR-PLARTLSVAGLPGKK | C97H146ClN23O24 | Details |
| SIVmac239-75;YVDRFYKSLRAEQTD | C84H127N23O27 | Details |
| TAT (47-57), TAMRA-labeled;TAMRA-YGRKKRRQRRR | C93H142ClN35O20 | Details |
| SIVmac239-56;PAPQQGQLREPSGSD | C65H105N21O25 | Details |
| SIVmac239-99;CWNCGKEGHSARQCR | C68H107N27O21S3 | Details |
| SIVmac239-76;FYKSLRAEQTDAAVK | C77H123N21O24 | Details |
| SIVmac239-62;EQIQWMYRQQNPIPV | C87H132N24O24S | Details |
| SIVmac239-66;NIYRRWIQLGLQKCV | C86H140N26O20S | Details |
| SIVmac239-88;TACQGVGGPGQKARL | C59H103N21O19S | Details |
| SIVmac239-73;GPKEPFQSYVDRFYK | C88H125N21O24 | Details |
| SIVmac239-44;GFQALSEGCTPYDIN | C70H103N17O25S | Details |
| SOAT1/ACAT1 (163-171)??;DEGRLVLEF | Details |
| Translation Initiation Factor 2B, pS13, FAM-labeled??;5-FAM-RRAAEELDSRAG-pS-PQL-NH2 | Details |
| SIVmac239-91;ARLMAEALKEALAPV | C70H123N19O20S | Details |
| SIVmac239-8;YMLKHVVWAANELDR | C84H129N23O22S | Details |
| SIVmac239-77;LRAEQTDAAVKNWMT | C74H120N22O24S | Details |
| SIVmac239-59;GSDIAGTTSSVDEQI | C59H98N16O28 | Details |
| SIVmac239-48;MLNCVGDHQAAMQII | C69H116N20O20S3 | Details |
| SIVmac239-5;EKIRLRPNGKKKYML | C84H148N26O20S | Details |
| SIVmac239-85;GLGVNPTLEEMLTAC | C65H110N16O23S2 | Details |
| SIVmac239-55;QHPQPAPQQGQLREP | C73H115N25O23 | Details |
| SIVmac239-43;EVVPGFQALSEGCTP | C67H104N16O23S | Details |
| Sulforhodamine 101-YSRALpSRQLSS;Sulforhodamine101-YSRAL-pS-RQLSS | C89H125N21O25S2 | Details |
| SIVmac239-74;PFQSYVDRFYKSLRA | C88H129N23O23 | Details |
| TNF-α (72-82), human;PLAQAVRSSSR | C48H86N18O16 | Details |
| Transcriptional Regulator Peptide;NCREKA | C27H49N11O10S | Details |
| SIVmac239-64;QQNPIPVGNIYRRWI | C85H132N26O21 | Details |
| SIVmac239-47;DINQMLNCVGDHQAA | C65H105N21O24S2 | Details |
| SIVmac239-9;HVVWAANELDRFGLA | C78H116N22O21 | Details |
| SIVmac239-68;LGLQKCVRMYNPTNI | C76H128N22O21S2 | Details |
| SIVmac239-41;IEEKKFGAEVVPGFQ | C78H120N18O23 | Details |
| Src Peptide Substrate;EFEYAFF | C49H57N7O13 | Details |
| Substance P, TAMRA-labeled;TAMRA-RPKPQQFFGLM-NH2 | C92H122ClN21O19S | Details |
| SIVmac239-92;AEALKEALAPVPIPF | C75H120N16O20 | Details |
| SIVmac239-96;AAQQRGPRKPIKCWN | C76H125N27O19S | Details |
| Survivin??;ELTLGEFLKL | Details |
| Synapsin I-derived peptide, FAM-labeled??;5-FAM-LRRRLSDANF-NH2 | Details |
| TRP-1, Fragment??;MSLQRQFL | Details |
| Transduction Peptide 1 (α II);SSLTSRDFGSWYASR | C75H110N22O25 | Details |
| SIVmac239-40;WVKLIEEKKFGAEVV | C86H137N19O22 | Details |
| SynB1;RGGRLSYSRRRFSTSTGRA | C89H151N37O27 | Details |
| SIVmac239-70;MYNPTNILDVKQGPK | C76H124N20O23S | Details |
| SIVmac239-42;KFGAEVVPGFQALSE | C73H111N17O22 | Details |
| T20-Lys(FAM);Ac-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF-K(FAM)-NH2 | Details |
| TNO113;DABCYL-(γ-Abu)-Pro-Cha-Abu-Smc-His-Ala-Glu(EDANS)-Ala-Lys-NH2(Smc=S-Methyl-L-Cysteine) | C76H107N19O15S2 | Details |
| SIVmac239-80;WMTQTLLIQNANPDC | C75H118N20O24S2 | Details |
| SIVmac239-94;APVPIPFAAAQQRGP | C70H110N20O18 | Details |
| SIVmac239-78;QTDAAVKNWMTQTLL | C75H122N20O24S | Details |
| Product Total： Product Page： | ||||
| 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 | ||||